Iconovos vd Johan Wäborg kommenterar helårsresultatet för 2020 (only in Swedish)
Inhalationsbolaget Iconovo har idag publicerat bokslutskommunikén för 2020 som visar högre omsättningssiffror jämfört med året innan. Under…
In search for vaccinations without cold storage – CTO Orest Lastow in MEDTECH Outlook
Dr. Orest Lastow, CTO and Founder
After an unprecedented year in the covid-19 pandemic, the challenges with vaccines requiring cold storage,…
Great progress for Iconovo’s major investment ICOpre
Biostock published February 8th an article about Iconovo that can be found in its entirety below
Iconovo recently submitted the first two patent applications…
Second ICOres® patent granted in the United States
United States Patent and Trademark Office has announced the intention to grant a patent (Notice of Allowance) regarding Iconovo’s inhalation device,…
Dr. Kyrre Thalberg new Senior Advisor in formulation development
Iconovo AB (publ) has appointed dr. Kyrre Thalberg to be Senior Advisor in formulation development.
Dr. Thalberg is an internationally renowned…
The first two ICOpre® patents filed
Iconovo AB (publ) has filed two ICOpre® patent applications.
ICOpre® is Iconovo’s new inhalation platform and builds on novel proprietary technology…
Iconovo aims to reach ambitious goals in 2021
Biostock published January 28th an article about Iconovo that can be found in its entirety below
Yesterday, Iconovo presented its business goals for…
VD Johan Wäborg presenterar Iconovo på Aktiedagen den 27 januari 2021 (only in Swedish)
Bolagspresentation av Iconovo från Aktiedagen den 27 januari 2021.
Kontakter
Johan Wäborg, VD
+46 707 78 51 71
…
Kommande presentationer av Iconovo (only in Swedish)
Iconovo kommer under kvartalet att delta på följande events och där presentera bolaget.
Aktiespararna – Aktiedagen Lund
Presentation…
Iconovo has reached several milestones during 2020
Biostock published January 18th an article about Iconovo that can be found in its entirety below
2020 was an eventful year for Iconovo, which included…
Iconovo participates at Aktiedagen by Aktiespararna, Lund, 27th January 2021 10:15am
On January 27, we will participate and present Iconovo at Aktiedagen Lund.
Production information
Location: Elite Hotel Ideon, Scheelevägen…
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se
CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se